Apsis Aerocom SME
smeUpcoming
GMP
₹0
smeUpcoming
Apsis Aerocom SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹0
Investment Timeline
🔓
IPO Open
11 Mar 2026
🔒
IPO Close
13 Mar 2026
🎲
Allotment
16 Mar 2026
🔔
Listing
18 Mar 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
AVOID
43.8/100
🎯 Application Strategy
Action: ⛔ AVOID - Better opportunities available elsewhere
Lots: NOT RECOMMENDED
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
⭐ Strong subscription demand showing healthy investor interest
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
❌ Risk of listing at discount or minimal gains
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹104.0 - ₹110.0
📦Lot Size
1200 shares
💰Issue Size
₹33.95 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Apsis Aerocom SME?
As of today, the Grey Market Premium (GMP) for Apsis Aerocom SME is ₹0, which is approximately null of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Apsis Aerocom SME?
Our AI algorithm currently rates this IPO as "AVOID" with a score of 43.8/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Apsis Aerocom SME be announced?
The allotment status for Apsis Aerocom SME is expected to be finalized on 16 Mar 2026. Investors can check their status on the registrar's website.
What is the listing date for Apsis Aerocom SME?
Shares of Apsis Aerocom SME are proposed to be listed on stock exchanges on 18 Mar 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.